Enhanced NMDA receptor-dependent LTP in the epileptic CA1 area via upregulation of NR2B

Lorenz Müller, Tursonjan Tokay, Katrin Porath, Rüdiger Köhling, Timo Kirschstein

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Impairment of synaptic plasticity such as long-term potentiation (LTP) is a common finding in various animal models of a number of neurodegenerative disorders. While cognitive deficits associated with these models are plausibly attributed to impaired plasticity, it is an intriguing question whether learning impairment correlates in general with compromised synaptic plasticity. In the present study, we have addressed this issue and discovered an enhancement of theta-burst stimulation-induced LTP at Schaffer collateral-CA1 synapses from chronically epileptic animals. The LTP enhancement was abolished by the NMDA receptor 2B (NR2B) blocker Ro 25-6981 (1μM) while it was preserved following application of the NR2A blocker NVP-AAM077 (50nM). Moreover, pharmacological characterization of intracellularly recorded excitatory postsynaptic potentials (EPSP) from CA1 pyramidal neurons indicated an increased NR2B/NR2A ratio in epileptic tissue, and NMDA receptor mediated excitatory postsynaptic currents showed significantly longer decay times. Quantitative reverse-transcriptase PCR confirmed the transcriptional up-regulation of NR2B-mRNA in chronically epileptic animals. To test the significance for epileptiform activity, recurrent epileptiform discharges (REDs) in the CA1 area induced by bath application of either high K+ (8mM) plus gabazine (5μM) or 4-aminopyridine (50μM), were also characterized pharmacologically. While in control slices the presence of Ro 25-6981 had no effect on the RED frequency, NR2B inhibition significantly increased epileptic activity in tissue from epileptic animals. Our results demonstrate that CA1 synapses in chronically epileptic tissue can undergo an LTP enhancement due to an NR2B up-regulation in CA1 pyramidal neurons. On the network level, this up-regulation appears to be a compensatory process, since blockade of these receptors leaves the tissue more susceptible to hyperexcitability.

Original languageEnglish
Pages (from-to)183-193
Number of pages11
JournalNeurobiology of Disease
Volume54
DOIs
Publication statusPublished - Jun 2013
Externally publishedYes

Fingerprint

Long-Term Potentiation
N-Methyl-D-Aspartate Receptors
Up-Regulation
Neuronal Plasticity
Pyramidal Cells
Excitatory Postsynaptic Potentials
Synapses
4-Aminopyridine
Reverse Transcriptase Polymerase Chain Reaction
Baths
Neurodegenerative Diseases
Hippocampus
Animal Models
NR2B NMDA receptor
Learning
Pharmacology
Messenger RNA
Ro 25-6981

Keywords

  • NVP-AAM077
  • Pilocarpine
  • Ro 25-6981
  • Synaptic plasticity

ASJC Scopus subject areas

  • Neurology

Cite this

Enhanced NMDA receptor-dependent LTP in the epileptic CA1 area via upregulation of NR2B. / Müller, Lorenz; Tokay, Tursonjan; Porath, Katrin; Köhling, Rüdiger; Kirschstein, Timo.

In: Neurobiology of Disease, Vol. 54, 06.2013, p. 183-193.

Research output: Contribution to journalArticle

Müller, Lorenz ; Tokay, Tursonjan ; Porath, Katrin ; Köhling, Rüdiger ; Kirschstein, Timo. / Enhanced NMDA receptor-dependent LTP in the epileptic CA1 area via upregulation of NR2B. In: Neurobiology of Disease. 2013 ; Vol. 54. pp. 183-193.
@article{915cb391818c45d28b17fdd39f5b4b62,
title = "Enhanced NMDA receptor-dependent LTP in the epileptic CA1 area via upregulation of NR2B",
abstract = "Impairment of synaptic plasticity such as long-term potentiation (LTP) is a common finding in various animal models of a number of neurodegenerative disorders. While cognitive deficits associated with these models are plausibly attributed to impaired plasticity, it is an intriguing question whether learning impairment correlates in general with compromised synaptic plasticity. In the present study, we have addressed this issue and discovered an enhancement of theta-burst stimulation-induced LTP at Schaffer collateral-CA1 synapses from chronically epileptic animals. The LTP enhancement was abolished by the NMDA receptor 2B (NR2B) blocker Ro 25-6981 (1μM) while it was preserved following application of the NR2A blocker NVP-AAM077 (50nM). Moreover, pharmacological characterization of intracellularly recorded excitatory postsynaptic potentials (EPSP) from CA1 pyramidal neurons indicated an increased NR2B/NR2A ratio in epileptic tissue, and NMDA receptor mediated excitatory postsynaptic currents showed significantly longer decay times. Quantitative reverse-transcriptase PCR confirmed the transcriptional up-regulation of NR2B-mRNA in chronically epileptic animals. To test the significance for epileptiform activity, recurrent epileptiform discharges (REDs) in the CA1 area induced by bath application of either high K+ (8mM) plus gabazine (5μM) or 4-aminopyridine (50μM), were also characterized pharmacologically. While in control slices the presence of Ro 25-6981 had no effect on the RED frequency, NR2B inhibition significantly increased epileptic activity in tissue from epileptic animals. Our results demonstrate that CA1 synapses in chronically epileptic tissue can undergo an LTP enhancement due to an NR2B up-regulation in CA1 pyramidal neurons. On the network level, this up-regulation appears to be a compensatory process, since blockade of these receptors leaves the tissue more susceptible to hyperexcitability.",
keywords = "NVP-AAM077, Pilocarpine, Ro 25-6981, Synaptic plasticity",
author = "Lorenz M{\"u}ller and Tursonjan Tokay and Katrin Porath and R{\"u}diger K{\"o}hling and Timo Kirschstein",
year = "2013",
month = "6",
doi = "10.1016/j.nbd.2012.12.011",
language = "English",
volume = "54",
pages = "183--193",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Enhanced NMDA receptor-dependent LTP in the epileptic CA1 area via upregulation of NR2B

AU - Müller, Lorenz

AU - Tokay, Tursonjan

AU - Porath, Katrin

AU - Köhling, Rüdiger

AU - Kirschstein, Timo

PY - 2013/6

Y1 - 2013/6

N2 - Impairment of synaptic plasticity such as long-term potentiation (LTP) is a common finding in various animal models of a number of neurodegenerative disorders. While cognitive deficits associated with these models are plausibly attributed to impaired plasticity, it is an intriguing question whether learning impairment correlates in general with compromised synaptic plasticity. In the present study, we have addressed this issue and discovered an enhancement of theta-burst stimulation-induced LTP at Schaffer collateral-CA1 synapses from chronically epileptic animals. The LTP enhancement was abolished by the NMDA receptor 2B (NR2B) blocker Ro 25-6981 (1μM) while it was preserved following application of the NR2A blocker NVP-AAM077 (50nM). Moreover, pharmacological characterization of intracellularly recorded excitatory postsynaptic potentials (EPSP) from CA1 pyramidal neurons indicated an increased NR2B/NR2A ratio in epileptic tissue, and NMDA receptor mediated excitatory postsynaptic currents showed significantly longer decay times. Quantitative reverse-transcriptase PCR confirmed the transcriptional up-regulation of NR2B-mRNA in chronically epileptic animals. To test the significance for epileptiform activity, recurrent epileptiform discharges (REDs) in the CA1 area induced by bath application of either high K+ (8mM) plus gabazine (5μM) or 4-aminopyridine (50μM), were also characterized pharmacologically. While in control slices the presence of Ro 25-6981 had no effect on the RED frequency, NR2B inhibition significantly increased epileptic activity in tissue from epileptic animals. Our results demonstrate that CA1 synapses in chronically epileptic tissue can undergo an LTP enhancement due to an NR2B up-regulation in CA1 pyramidal neurons. On the network level, this up-regulation appears to be a compensatory process, since blockade of these receptors leaves the tissue more susceptible to hyperexcitability.

AB - Impairment of synaptic plasticity such as long-term potentiation (LTP) is a common finding in various animal models of a number of neurodegenerative disorders. While cognitive deficits associated with these models are plausibly attributed to impaired plasticity, it is an intriguing question whether learning impairment correlates in general with compromised synaptic plasticity. In the present study, we have addressed this issue and discovered an enhancement of theta-burst stimulation-induced LTP at Schaffer collateral-CA1 synapses from chronically epileptic animals. The LTP enhancement was abolished by the NMDA receptor 2B (NR2B) blocker Ro 25-6981 (1μM) while it was preserved following application of the NR2A blocker NVP-AAM077 (50nM). Moreover, pharmacological characterization of intracellularly recorded excitatory postsynaptic potentials (EPSP) from CA1 pyramidal neurons indicated an increased NR2B/NR2A ratio in epileptic tissue, and NMDA receptor mediated excitatory postsynaptic currents showed significantly longer decay times. Quantitative reverse-transcriptase PCR confirmed the transcriptional up-regulation of NR2B-mRNA in chronically epileptic animals. To test the significance for epileptiform activity, recurrent epileptiform discharges (REDs) in the CA1 area induced by bath application of either high K+ (8mM) plus gabazine (5μM) or 4-aminopyridine (50μM), were also characterized pharmacologically. While in control slices the presence of Ro 25-6981 had no effect on the RED frequency, NR2B inhibition significantly increased epileptic activity in tissue from epileptic animals. Our results demonstrate that CA1 synapses in chronically epileptic tissue can undergo an LTP enhancement due to an NR2B up-regulation in CA1 pyramidal neurons. On the network level, this up-regulation appears to be a compensatory process, since blockade of these receptors leaves the tissue more susceptible to hyperexcitability.

KW - NVP-AAM077

KW - Pilocarpine

KW - Ro 25-6981

KW - Synaptic plasticity

UR - http://www.scopus.com/inward/record.url?scp=84876332735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876332735&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2012.12.011

DO - 10.1016/j.nbd.2012.12.011

M3 - Article

VL - 54

SP - 183

EP - 193

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -